ATOPIX THERAPEUTICS
Atopix Therapeutics Limited is a privately held, clinical-stage, biopharmaceutical company based in Oxford, UK, with an innovative approach to allergy. The company is developing a novel class of oral anti-allergic medicines, called CRTH2 antagonists, to treat atopic dermatitis, asthma and allergic rhinitis. Its lead candidate is currently being studied in a Phase 2 clinical trial for moderate to severe atopic dermatitis in several leading European dermatology centres.
ATOPIX THERAPEUTICS
Industry:
Biotechnology Life Science Medical
Founded:
2012-01-01
Address:
Abingdon, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.atopixtherapeutics.co.uk
Total Employee:
1+
Status:
Closed
Contact:
(440) 123-5841
Email Addresses:
[email protected]
Total Funding:
10.46 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Nginx DigiCert SSL CloudFront Google Adsense AdBlock Acceptable Ads Google Adsense For Domains Thawte SSL
Current Advisors List
Current Employees Featured
Investors List
SV Health Investors
SV Health Investors investment in Venture Round - Atopix Therapeutics
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - Atopix Therapeutics
Wellington Partners
Wellington Partners investment in Series A - Atopix Therapeutics
SR One
SR One investment in Series A - Atopix Therapeutics
Bessemer Venture Partners
Bessemer Venture Partners investment in Series A - Atopix Therapeutics
Red Abbey Venture Partners
Red Abbey Venture Partners investment in Series A - Atopix Therapeutics
MPM Capital
MPM Capital investment in Series A - Atopix Therapeutics
Biomedical Catalyst Fund
Biomedical Catalyst Fund investment in Grant - Atopix Therapeutics
Official Site Inspections
http://www.atopixtherapeutics.co.uk
- Host name: 104.247.82.54
- IP address: 104.247.82.54
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto